Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes

Go back to Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Delayed: 2.24 -0.02 (0.88%)
Previous Close $2.26    52 Week High $19.62 
Open $2.25    52 Week Low $7.65 
Day High $2.26    P/E N/A 
Day Low $2.22    EPS $-0.22 
Volume 1,044,611       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.93 -0.12 (0.8%)
Previous Close $15.05    52 Week High $5.58 
Open $14.90    52 Week Low $3.60 
Day High $14.97    P/E N/A 
Day Low $14.86    EPS $0.00 
Volume 8,277,863       

SANOFI (NASDAQ: SNY) Delayed: 44.24 -0.09 (0.2%)
Previous Close $44.33    52 Week High $44.76 
Open $44.17    52 Week Low $36.81 
Day High $44.36    P/E N/A 
Day Low $44.03    EPS $0.00 
Volume 1,695,048